Olivier Brandicourt
|
Dr. Olivier Brandicourt MD |
|
|---|---|
 |
|
| Born |
13 February 1956 Casablanca, Morocco |
| Nationality | French |
| Occupation | CEO of Sanofi |
Olivier Brandicourt (born 13 February 1956 in Casablanca) is a French business executive and physician, and the current chief executive officer of Sanofi.
Olivier Brandicourt started his career as a physician at the Institute of Infectious and Tropical Diseases of the Pitié-Salpêtrière Hospital in Paris, where he worked primarily on malaria. He practised medicine in the Republic of the Congo for two years.
Olivier Brandicourt was chief executive officer and chairman of the board of management of Bayer HealthCare AG, where he was responsible for leading the company’s healthcare portfolio globally, encompassing pharmaceuticals, consumer care, animal health and medical care businesses. He also served as a member of the executive leadership team of Pfizer Inc. and consecutively led several of the firm’s global business units. In 2007, he was the supervisor of the failed launch of the Exubera.
In February 2015, Olivier Brandicourt was appointed as the chief executive officer of Sanofi. His golden handshake of US$4.5 million upon taking on the appointment was criticized by French Ministers Stéphane Le Foll and Ségolène Royal.
In November 2015, Sanofi announced its 2020 Strategic Plan that implies reshaping its activities into 3 portfolios: Diabetes, cardiovascular, and vaccines. In May 2016, Olivier Brandicourt announced a reshuffle in the company's management, in line with the 2020 Strategic Plan.
...
Wikipedia